RxDoctor Payments Data

Hugh Newman, DO

Physical Medicine & Rehabilitation · Altoona, PANPI 1801826136

Payments from drug & device makers

$739in general payments, 2019–2025

Across 8 payments — averaging $92.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$724
  • Pfizer$15

What the payments were for

  • Food & beverage$739100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$739 in reported general payments places this provider in the 75th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$368,760
Medicare patients
568
Services billed
4,610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$44,114
JardianceEmpagliflozin18$8,586
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine183$7,202
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,640
Bromocriptine Mesylate36$4,991
Enoxaparin Sodium17$2,741
Temazepam63$2,501
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine147$2,195
Dantrolene Sodium30$1,808
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$1,532
Morphine Sulfate22$810
Pantoprazole Sodium98$782
Methylphenidate Hcl46$751
Midodrine Hcl18$712
Atorvastatin Calcium91$692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$44,11483 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

Other physical medicine & rehabilitation in Altoona

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →